0 By jay In Press ReleasesPosted September 22, 2020Axial Biotherapeutics Appoints Federico Bolognani, M.D., Ph.D., Vice President and Head of Clinical ScienceSeptember 22, 2020 READ MORE
0 By jay In Press ReleasesPosted September 15, 2020Axial Biotherapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceSeptember, 15, 2020 READ MORE
0 By jay In Press ReleasesPosted August 17, 2020Axial Biotherapeutics to Present at The JMP Securities CNS ForumAugust 12, 2020 READ MORE
1 By jay In Press ReleasesPosted July 28, 2020Axial Biotherapeutics Announces a Research Grant Award from The Michael J. Fox Foundation for the Development of an Enteric Nervous System Model to Assess Novel Parkinson’s Disease TherapeuticsJuly 28, 2020 READ MORE
0 By jay In Press ReleasesPosted May 27, 2020Axial Biotherapeutics to Present at the Jefferies Virtual Global Healthcare ConferenceMay 27, 2020 READ MORE
0 By jay In Press ReleasesPosted May 22, 2020Axial Biotherapeutics to Present Virtual Presentation at American Society of Clinical Psychopharmacology (ASCP) 2020 Annual MeetingMay 22, 2020 READ MORE
2 By jay In Press ReleasesPosted April 2, 2020Axial Biotherapeutics Announces Positive Topline Results from Phase 1b/2a Clinical Trial of AB-2004 for the Treatment of Autism Spectrum DisorderApril 02, 2020 READ MORE
0 By jay In Press ReleasesPosted March 13, 2020Axial Biotherapeutics to Present at the Chardan 2nd Annual Microbiome Medicines Virtual SummitMarch 10, 2020 READ MORE
0 By jay In Press ReleasesPosted February 12, 2020Axial Biotherapeutics Strengthens and Expands Board of Directors and Leadership TeamFebruary 12, 2020 READ MORE
1 By jay In Press ReleasesPosted February 5, 2020Axial Biotherapeutics to Present at the Centre for Clinical Trials in Rare Neurodevelopmental Disorders’ Emerging Management Therapies for Childhood Neurodevelopmental Disorders Scientific SymposiumFebruary 5, 2020 READ MORE
